FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Fusion Antibodies and Queen’s University Belfast Awarded a £453,000 Grant from Invest Northern Ireland
The two organisations will use the funds to accelerate the discovery of novel therapeutic and diagnostic antibodies with validated anti-infective properties against COVID-19. Building on strong scientific knowhow, a new antibody development platform will be created that will help realise the vision of producing a breakthrough therapeutic that directly targets SARS-CoV-2.
Kayentis, a global provider of digital data capture systems for clinical trials, today announces it has raised €7M (approx. $8.3M) in growth capital.
Kayentis is active in the global electronic Clinical Outcome Assessment (eCOA) market, which is expected to reach $2.6 billion by 2027. Market growth in eCOA – a method of capturing outcomes data electronically in clinical trials – is driven by the clinical trials industry.
MapLight Therapeutics Receives $8.1 Million For Parkinson’s Disease Research
To undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering psychiatric symptoms in Parkinson's disease.
Eluminex Biosciences Announces Closing of $50 Million Series A Financing
Eluminex also announced that Charles Semba, MD, has joined Eluminex as Chief Medical Officer
Ginkgo Bioworks Announces U.S. International Development Finance Corporation Approved a Loan of Up to $1.1 billion
"DFC is proud to support this American company in the fight against COVID-19," said DFC Chief Executive Officer Adam Boehler. "Ginkgo is working to provide Americans with needed testing capacity and vaccine supplies which will facilitate our recovery from this global pandemic."
Elevian Announces $15 Million Equity Financing: Expands Leadership Team As it Advances Preclinical Studies of rGDF11 in Stroke and Other Age-Related Diseases
The financing was led by Prime Movers Lab and involved the participation of Bold Capital Partners, For Good Ventures, Kizoo Ventures, Lauder Partners, Longevity Fund, SavEarth Fund, WTI, and several prominent angels.
Mekonos Raises $4.6M – New Capital & Expertise Will Accelerate Development of the Company’s Chip (SoC) & Commercial Partnerships
The company will use the new capital to accelerate the SoC platform for its current and new commercial partnerships.
AliveCor Closes $65 Million Series E Financing: To Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, & Providers
Their $65 million Series E financing led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, and Bold Capital Partners.
Sheltowee Medical Device Fund Breaks Escrow Making Its 1st Investment in Embolic Acceleration, LLC
Sheltowee Medical Device Fund investment thesis is to target seed and early stage medical device companies in the cardiovascular, orthopedics, and digital wearables market segments, all areas of expertise by the leadership team and Scientific Advisory Board of the fund.
Medical Device News Magazine